SCHEDULE: Jane Street Group Discloses 5.6% Stake in Hinge Health

Jane Street Group, LLC and its affiliates have reported a beneficial ownership of 5.6% in Hinge Health, Inc.'s Class A Common Stock.

Summary

• Jane Street Group, LLC, along with its subsidiaries Jane Street Capital, LLC, Jane Street Options, LLC, and Jane Street Global Trading, LLC, has filed a Schedule 13G.
• The group collectively beneficially owns 2,130,181 shares of Hinge Health, Inc.'s Class A Common Stock.
• This aggregate ownership represents 5.6% of the Class A Common Stock outstanding.
• Jane Street Group, LLC, as the parent holding company, holds shared voting and dispositive power over all 2,130,181 shares.
• Individual beneficial ownership percentages for the subsidiaries are: Jane Street Capital, LLC (1.3%), Jane Street Options, LLC (0.2%), and Jane Street Global Trading, LLC (4.2%).
• The filing certifies that the securities were not acquired for the purpose of changing or influencing control of Hinge Health, Inc.

Sentiment

Score: 5

Explanation: The filing is a factual disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the issuer's performance or prospects.

Positives

• NA

Negatives

• NA

Risks

• NA

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance regarding Hinge Health, Inc.'s future performance or operations.

Industry Context

This filing indicates a significant passive investment by a prominent financial institution in Hinge Health, Inc., a company operating in the digital musculoskeletal health sector. Such disclosures can signal institutional interest in the healthcare technology space.

Stakeholder Impact

• Shareholders: The disclosure of a new or increased significant institutional holder can influence market perception and potentially liquidity for Hinge Health, Inc.'s stock.

Next Steps

• NA

Key Dates

Keywords

Hinge Health, Jane Street Group, Beneficial Ownership, Class A Common Stock, SEC Filing, Institutional Investor, Equity Stake, Healthcare Technology